Company: IMRX
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001790340-25-000104
Chunk: 313

Company: Immuneering Corp
Filing Date: 2025-08-13
Form: 10-Q
Item: Part II, Item 1A
Chunk 313
---
 Financial Officer pursuant to Rule 13a-14(a)/15d-14(a).*32.1Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350.**32.2Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350.**101.INSInline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.*101.SCHInline XBRL Taxonomy Extension Schema Document.*101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document.*101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document.*101.LABInline XBRL Taxonomy Extension Label Linkbase Document.*101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document.*104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)*

*    Filed herewith.

**    Furnished herewith.

#    Indicates management contract or compensatory plan.

94

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, duly authorized. 

IMMUNEERING CORPORATIONDate: August 13, 2025By:/s/ Benjamin J. ZeskindName:Benjamin J. Zeskind, Ph.D.Title:Co-Founder, President, Chief Executive Officer and Director (Principal Executive Officer)Date: August 13, 2025By:/s/ Mallory MoralesName:Mallory MoralesTitle:Chief Accounting Officer and Treasurer(Principal Financial Officer and Principal Accounting Officer)

95